These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25525603)

  • 1. Conspicuity of peripheral zone prostate cancer on computed diffusion-weighted imaging: comparison of cDWI1500, cDWI2000, and cDWI3000.
    Vural M; Ertaş G; Onay A; Acar Ö; Esen T; Sağlıcan Y; Zengingönül HP; Akpek S
    Biomed Res Int; 2014; 2014():768291. PubMed ID: 25525603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed high b-value diffusion-weighted imaging improves lesion contrast and conspicuity in prostate cancer.
    Feuerlein S; Davenport MS; Krishnaraj A; Merkle EM; Gupta RT
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):155-60. PubMed ID: 25732928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal adenocarcinoma and focal autoimmune pancreatitis.
    Ichikawa S; Kromrey ML; Motosugi U; Onishi H
    Abdom Radiol (NY); 2021 Feb; 46(2):636-646. PubMed ID: 32740865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and Diagnostic Performance of Voxelwise Computed Diffusion-Weighted Imaging in Breast Cancer.
    Zhou J; Chen E; Xu H; Ye Q; Li J; Ye S; Cheng Q; Zhao L; Su MY; Wang M
    J Magn Reson Imaging; 2019 Jun; 49(6):1610-1616. PubMed ID: 30328211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the impact of computed high b-value diffusion-weighted imaging on prostate cancer detection.
    Verma S; Sarkar S; Young J; Venkataraman R; Yang X; Bhavsar A; Patil N; Donovan J; Gaitonde K
    Abdom Radiol (NY); 2016 May; 41(5):934-45. PubMed ID: 27193792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate.
    Maas MC; Fütterer JJ; Scheenen TW
    Invest Radiol; 2013 Nov; 48(11):779-86. PubMed ID: 23907102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed diffusion-weighted MR imaging for visualization of pancreatic adenocarcinoma: Comparison with acquired diffusion-weighted imaging.
    Fukukura Y; Kumagae Y; Hakamada H; Shindo T; Takumi K; Kamimura K; Nakajo M; Umanodan A; Yoshiura T
    Eur J Radiol; 2017 Oct; 95():39-45. PubMed ID: 28987696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Exponential ADC (eADC) and Computed DWI (cDWI) for the Detection of Prostate Cancer.
    Sprinkart AM; Marx C; Träber F; Block W; Thomas D; Schild H; Kukuk GM; Mürtz P
    Rofo; 2018 Aug; 190(8):758-766. PubMed ID: 30045400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing b-values for accurate depiction of pancreatic cancer with tumor-associated pancreatitis on computed diffusion-weighted imaging.
    Tokunaga K; Arizono S; Shimizu H; Fujimoto K; Kurata M; Minamiguchi S; Isoda H; Togashi K
    Clin Imaging; 2020 May; 61():20-26. PubMed ID: 31954347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection.
    Rosenkrantz AB; Chandarana H; Hindman N; Deng FM; Babb JS; Taneja SS; Geppert C
    Eur Radiol; 2013 Nov; 23(11):3170-7. PubMed ID: 23756956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate Cancer Detection Using Computed Very High b-value Diffusion-weighted Imaging: How High Should We Go?
    Rosenkrantz AB; Parikh N; Kierans AS; Kong MX; Babb JS; Taneja SS; Ream JM
    Acad Radiol; 2016 Jun; 23(6):704-11. PubMed ID: 26992738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility Study of Synthetic Diffusion-Weighted MRI in Patients with Breast Cancer in Comparison with Conventional Diffusion-Weighted MRI.
    Choi BH; Baek HJ; Ha JY; Ryu KH; Moon JI; Park SE; Bae K; Jeon KN; Jung EJ
    Korean J Radiol; 2020 Sep; 21(9):1036-1044. PubMed ID: 32691539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image quality and diagnostic accuracy of complex-averaged high b value images in diffusion-weighted MRI of prostate cancer.
    Kordbacheh H; Seethamraju RT; Weiland E; Kiefer B; Nickel MD; Chulroek T; Cecconi M; Baliyan V; Harisinghani MG
    Abdom Radiol (NY); 2019 Jun; 44(6):2244-2253. PubMed ID: 30838425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.
    Rosenkrantz AB; Hindman N; Lim RP; Das K; Babb JS; Mussi TC; Taneja SS
    J Magn Reson Imaging; 2013 Sep; 38(3):694-700. PubMed ID: 23371846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biparametric
    Scialpi M; Prosperi E; D'Andrea A; Martorana E; Malaspina C; Palumbo B; Orlandi A; Falcone G; Milizia M; Mearini L; Aisa MC; Scialpi P; DE Dominicis C; Bianchi G; Sidoni A
    Anticancer Res; 2017 Mar; 37(3):1263-1271. PubMed ID: 28314291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of computed and voxelwise computed diffusion-weighted imaging in breast cancer.
    Cheng Q; Ye S; Fu C; Zhou J; He X; Miao H; Xu N; Wang M
    Br J Radiol; 2019 Aug; 92(1100):20180978. PubMed ID: 31291125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed diffusion-weighted imaging using 1.5-T magnetic resonance imaging for prostate cancer diagnosis.
    Yoshida R; Yoshizako T; Katsube T; Tamaki Y; Ishikawa N; Kitagaki H
    Clin Imaging; 2017; 41():78-82. PubMed ID: 27829196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different mathematical models of diffusion-weighted prostate MR imaging.
    Quentin M; Blondin D; Klasen J; Lanzman RS; Miese FR; Arsov C; Albers P; Antoch G; Wittsack HJ
    Magn Reson Imaging; 2012 Dec; 30(10):1468-74. PubMed ID: 22819178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.